Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiovascular Diseases
|
711 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Lymphocyte Count measurement
|
456 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
White Blood Cell Count procedure
|
1322 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Autoimmune Diseases
|
428 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Behcet Syndrome
|
243 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinogenesis
|
355 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Childhood Hodgkin Lymphoma
|
29 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Chronic kidney disease stage 5
|
194 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Colorectal Carcinoma
|
1962 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Coronary Artery Disease
|
1577 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1 | 2015 | 2015 | ||||||
Crohn Disease
|
1147 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hepatitis C
|
347 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1 | 2016 | 2016 | ||||||
Hodgkin Disease
|
148 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Kidney Failure, Acute
|
32 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Kidney Failure, Chronic
|
425 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Liver carcinoma
|
942 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Nasopharyngeal carcinoma
|
320 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Oligospermia
|
72 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm
|
1374 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Ulcerative Colitis
|
827 | 0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 | 0.010 | 1.000 | 1 | 2014 | 2014 |